Advertisement

Index by author

February 01, 1987; Volume 31,Issue 2

A

  1. Aiyar, N

    1. Phorbol ester-mediated inhibition of vasopressin and beta-adrenergic responses in a vascular smooth muscle cell line.
      N Aiyar, P Nambi, M Whitman, F L Stassen and S T Crooke
      Molecular Pharmacology February 1987, 31 (2) 180-184;

  2. Amlaiky, N

    1. Identification of the binding subunit of the D1-dopamine receptor by photoaffinity crosslinking.
      N Amlaiky, J G Berger, W Chang, R J McQuade and M G Caron
      Molecular Pharmacology February 1987, 31 (2) 129-134;

  3. Anders, M W

    1. Alpha-ketoacids stimulate rat renal cysteine conjugate beta-lyase activity and potentiate the cytotoxicity of S-(1,2-dichlorovinyl)-L-cysteine.
      A A Elfarra, L H Lash and M W Anders
      Molecular Pharmacology February 1987, 31 (2) 208-212;

B

  1. Balwierczak, J L

    1. The relationship between the binding site of [3H]-d-cis-diltiazem and that of other non-dihydropyridine calcium entry blockers in cardiac sarcolemma.
      J L Balwierczak, C L Johnson and A Schwartz
      Molecular Pharmacology February 1987, 31 (2) 175-179;

  2. Berger, J G

    1. Identification of the binding subunit of the D1-dopamine receptor by photoaffinity crosslinking.
      N Amlaiky, J G Berger, W Chang, R J McQuade and M G Caron
      Molecular Pharmacology February 1987, 31 (2) 129-134;

C

  1. Caron, M G

    1. Identification of the binding subunit of the D1-dopamine receptor by photoaffinity crosslinking.
      N Amlaiky, J G Berger, W Chang, R J McQuade and M G Caron
      Molecular Pharmacology February 1987, 31 (2) 129-134;

  2. Chang, W

    1. Identification of the binding subunit of the D1-dopamine receptor by photoaffinity crosslinking.
      N Amlaiky, J G Berger, W Chang, R J McQuade and M G Caron
      Molecular Pharmacology February 1987, 31 (2) 129-134;

  3. Chapekar, M S

    1. Synergistic effect of retinoic acid and calcium ionophore A23187 on differentiation, c-myc expression, and membrane tyrosine kinase activity in human promyelocytic leukemia cell line HL-60.
      M S Chapekar, K D Hartman, M C Knode and R I Glazer
      Molecular Pharmacology February 1987, 31 (2) 140-145;

  4. Cheng, Y C

    1. Inhibition of DNA primase by nucleoside triphosphates and their arabinofuranosyl analogs.
      W B Parker and Y C Cheng
      Molecular Pharmacology February 1987, 31 (2) 146-151;

  5. Churchill, P F

    1. Characterization of a rat liver cytochrome P-450UT-H cDNA clone and comparison of mRNA levels with catalytic activity.
      P F Churchill, S A Churchill, M V Martin and F P Guengerich
      Molecular Pharmacology February 1987, 31 (2) 152-158;

  6. Churchill, S A

    1. Characterization of a rat liver cytochrome P-450UT-H cDNA clone and comparison of mRNA levels with catalytic activity.
      P F Churchill, S A Churchill, M V Martin and F P Guengerich
      Molecular Pharmacology February 1987, 31 (2) 152-158;

  7. Costa, T

    1. GTPase and adenylate cyclase desensitize at different rates in NG108-15 cells.
      L Vachon, T Costa and A Herz
      Molecular Pharmacology February 1987, 31 (2) 159-168;

  8. Crooke, S T

    1. Phorbol ester-mediated inhibition of vasopressin and beta-adrenergic responses in a vascular smooth muscle cell line.
      N Aiyar, P Nambi, M Whitman, F L Stassen and S T Crooke
      Molecular Pharmacology February 1987, 31 (2) 180-184;

D

  1. Davis, K H

    1. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
      R A Lyon, K H Davis and M Titeler
      Molecular Pharmacology February 1987, 31 (2) 194-199;

E

  1. Elfarra, A A

    1. Alpha-ketoacids stimulate rat renal cysteine conjugate beta-lyase activity and potentiate the cytotoxicity of S-(1,2-dichlorovinyl)-L-cysteine.
      A A Elfarra, L H Lash and M W Anders
      Molecular Pharmacology February 1987, 31 (2) 208-212;

F

  1. Fleming, J T

    1. The levamisole receptor, a cholinergic receptor of the nematode Caenorhabditis elegans.
      J A Lewis, J T Fleming, S McLafferty, H Murphy and C Wu
      Molecular Pharmacology February 1987, 31 (2) 185-193;

  2. Franklin, M R

    1. Clotrimazole induction of cytochrome P-450: dose-differentiated isozyme induction.
      J K Ritter and M R Franklin
      Molecular Pharmacology February 1987, 31 (2) 135-139;

G

  1. Glazer, R I

    1. Synergistic effect of retinoic acid and calcium ionophore A23187 on differentiation, c-myc expression, and membrane tyrosine kinase activity in human promyelocytic leukemia cell line HL-60.
      M S Chapekar, K D Hartman, M C Knode and R I Glazer
      Molecular Pharmacology February 1987, 31 (2) 140-145;

  2. Guengerich, F P

    1. Characterization of a rat liver cytochrome P-450UT-H cDNA clone and comparison of mRNA levels with catalytic activity.
      P F Churchill, S A Churchill, M V Martin and F P Guengerich
      Molecular Pharmacology February 1987, 31 (2) 152-158;

H

  1. Hartman, K D

    1. Synergistic effect of retinoic acid and calcium ionophore A23187 on differentiation, c-myc expression, and membrane tyrosine kinase activity in human promyelocytic leukemia cell line HL-60.
      M S Chapekar, K D Hartman, M C Knode and R I Glazer
      Molecular Pharmacology February 1987, 31 (2) 140-145;

  2. Herz, A

    1. GTPase and adenylate cyclase desensitize at different rates in NG108-15 cells.
      L Vachon, T Costa and A Herz
      Molecular Pharmacology February 1987, 31 (2) 159-168;

J

  1. Johnson, C L

    1. The relationship between the binding site of [3H]-d-cis-diltiazem and that of other non-dihydropyridine calcium entry blockers in cardiac sarcolemma.
      J L Balwierczak, C L Johnson and A Schwartz
      Molecular Pharmacology February 1987, 31 (2) 175-179;

K

  1. Kellar, K J

    1. [3H]acetylcholine and [3H](-)nicotine label the same recognition site in rat brain.
      A M Martino-Barrows and K J Kellar
      Molecular Pharmacology February 1987, 31 (2) 169-174;

  2. Knode, M C

    1. Synergistic effect of retinoic acid and calcium ionophore A23187 on differentiation, c-myc expression, and membrane tyrosine kinase activity in human promyelocytic leukemia cell line HL-60.
      M S Chapekar, K D Hartman, M C Knode and R I Glazer
      Molecular Pharmacology February 1987, 31 (2) 140-145;

L

  1. Lash, L H

    1. Alpha-ketoacids stimulate rat renal cysteine conjugate beta-lyase activity and potentiate the cytotoxicity of S-(1,2-dichlorovinyl)-L-cysteine.
      A A Elfarra, L H Lash and M W Anders
      Molecular Pharmacology February 1987, 31 (2) 208-212;

  2. Lewis, J A

    1. The levamisole receptor, a cholinergic receptor of the nematode Caenorhabditis elegans.
      J A Lewis, J T Fleming, S McLafferty, H Murphy and C Wu
      Molecular Pharmacology February 1987, 31 (2) 185-193;

  3. Lyon, R A

    1. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
      R A Lyon, K H Davis and M Titeler
      Molecular Pharmacology February 1987, 31 (2) 194-199;

M

  1. Martin, M V

    1. Characterization of a rat liver cytochrome P-450UT-H cDNA clone and comparison of mRNA levels with catalytic activity.
      P F Churchill, S A Churchill, M V Martin and F P Guengerich
      Molecular Pharmacology February 1987, 31 (2) 152-158;

  2. Martino-Barrows, A M

    1. [3H]acetylcholine and [3H](-)nicotine label the same recognition site in rat brain.
      A M Martino-Barrows and K J Kellar
      Molecular Pharmacology February 1987, 31 (2) 169-174;

  3. McLafferty, S

    1. The levamisole receptor, a cholinergic receptor of the nematode Caenorhabditis elegans.
      J A Lewis, J T Fleming, S McLafferty, H Murphy and C Wu
      Molecular Pharmacology February 1987, 31 (2) 185-193;

  4. McQuade, R J

    1. Identification of the binding subunit of the D1-dopamine receptor by photoaffinity crosslinking.
      N Amlaiky, J G Berger, W Chang, R J McQuade and M G Caron
      Molecular Pharmacology February 1987, 31 (2) 129-134;

  5. Murphy, H

    1. The levamisole receptor, a cholinergic receptor of the nematode Caenorhabditis elegans.
      J A Lewis, J T Fleming, S McLafferty, H Murphy and C Wu
      Molecular Pharmacology February 1987, 31 (2) 185-193;

N

  1. Nambi, P

    1. Phorbol ester-mediated inhibition of vasopressin and beta-adrenergic responses in a vascular smooth muscle cell line.
      N Aiyar, P Nambi, M Whitman, F L Stassen and S T Crooke
      Molecular Pharmacology February 1987, 31 (2) 180-184;

O

  1. Ortiz de Montellano, P R

    1. Free radical pathways in the in vitro hepatic metabolism of phenelzine.
      P R Ortiz de Montellano and M D Watanabe
      Molecular Pharmacology February 1987, 31 (2) 213-219;

P

  1. Parker, W B

    1. Inhibition of DNA primase by nucleoside triphosphates and their arabinofuranosyl analogs.
      W B Parker and Y C Cheng
      Molecular Pharmacology February 1987, 31 (2) 146-151;

R

  1. Ritter, J K

    1. Clotrimazole induction of cytochrome P-450: dose-differentiated isozyme induction.
      J K Ritter and M R Franklin
      Molecular Pharmacology February 1987, 31 (2) 135-139;

S

  1. Schwartz, A

    1. The relationship between the binding site of [3H]-d-cis-diltiazem and that of other non-dihydropyridine calcium entry blockers in cardiac sarcolemma.
      J L Balwierczak, C L Johnson and A Schwartz
      Molecular Pharmacology February 1987, 31 (2) 175-179;

  2. Stassen, F L

    1. Phorbol ester-mediated inhibition of vasopressin and beta-adrenergic responses in a vascular smooth muscle cell line.
      N Aiyar, P Nambi, M Whitman, F L Stassen and S T Crooke
      Molecular Pharmacology February 1987, 31 (2) 180-184;

T

  1. Titeler, M

    1. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
      R A Lyon, K H Davis and M Titeler
      Molecular Pharmacology February 1987, 31 (2) 194-199;

V

  1. Vachon, L

    1. GTPase and adenylate cyclase desensitize at different rates in NG108-15 cells.
      L Vachon, T Costa and A Herz
      Molecular Pharmacology February 1987, 31 (2) 159-168;

W

  1. Waddell, K S

    1. In vivo effects of mercury (II) on deoxyuridine triphosphate nucleotidohydrolase, DNA polymerase (alpha, beta), and uracil-DNA glycosylase activities in cultured human cells: relationship to DNA damage, DNA repair, and cytotoxicity.
      M V Williams, T Winters and K S Waddell
      Molecular Pharmacology February 1987, 31 (2) 200-207;

  2. Watanabe, M D

    1. Free radical pathways in the in vitro hepatic metabolism of phenelzine.
      P R Ortiz de Montellano and M D Watanabe
      Molecular Pharmacology February 1987, 31 (2) 213-219;

  3. Whitman, M

    1. Phorbol ester-mediated inhibition of vasopressin and beta-adrenergic responses in a vascular smooth muscle cell line.
      N Aiyar, P Nambi, M Whitman, F L Stassen and S T Crooke
      Molecular Pharmacology February 1987, 31 (2) 180-184;

  4. Williams, M V

    1. In vivo effects of mercury (II) on deoxyuridine triphosphate nucleotidohydrolase, DNA polymerase (alpha, beta), and uracil-DNA glycosylase activities in cultured human cells: relationship to DNA damage, DNA repair, and cytotoxicity.
      M V Williams, T Winters and K S Waddell
      Molecular Pharmacology February 1987, 31 (2) 200-207;

  5. Winters, T

    1. In vivo effects of mercury (II) on deoxyuridine triphosphate nucleotidohydrolase, DNA polymerase (alpha, beta), and uracil-DNA glycosylase activities in cultured human cells: relationship to DNA damage, DNA repair, and cytotoxicity.
      M V Williams, T Winters and K S Waddell
      Molecular Pharmacology February 1987, 31 (2) 200-207;

  6. Wu, C

    1. The levamisole receptor, a cholinergic receptor of the nematode Caenorhabditis elegans.
      J A Lewis, J T Fleming, S McLafferty, H Murphy and C Wu
      Molecular Pharmacology February 1987, 31 (2) 185-193;
Back to top

In this issue

Advertisement